These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7187098)

  • 21. On the Colton model for clinical trials with delayed observations -- normally-distributed responses.
    Langenberg P; Srinivasan R
    Biometrics; 1981 Mar; 37(1):143-8. PubMed ID: 7248440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical problems in clinical trials.
    Schaffner KF
    J Med Philos; 1986 Nov; 11(4):297-315. PubMed ID: 3819602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision analysis and Bayesian methods in clinical trials.
    Berry DA
    Cancer Treat Res; 1995; 75():125-54. PubMed ID: 7640161
    [No Abstract]   [Full Text] [Related]  

  • 24. Interim analyses in clinical trials: classical vs. Bayesian approaches.
    Berry DA
    Stat Med; 1985; 4(4):521-6. PubMed ID: 4089353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis.
    Berry DA
    Clin Trials; 2005; 2(4):295-300; discussion 301-4, 364-78. PubMed ID: 16281428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bayesian equivalency test for two independent binomial proportions.
    Kawasaki Y; Shimokawa A; Yamada H; Miyaoka E
    J Biopharm Stat; 2016; 26(4):781-9. PubMed ID: 26322683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stopping rules and estimation problems in clinical trials.
    Hughes MD; Pocock SJ
    Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
    Atkinson AC; Biswas A
    Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends?
    Iorio A; Marcucci M
    Haemophilia; 2009 Jul; 15(4):900-3. PubMed ID: 19473413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ignorance is not bliss: Statistical power is not probability of trial success.
    Zierhut ML; Bycott P; Gibbs MA; Smith BP; Vicini P
    Clin Pharmacol Ther; 2016 Apr; 99(4):356-9. PubMed ID: 26331445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive power priors with empirical Bayes for clinical trials.
    Gravestock I; Held L;
    Pharm Stat; 2017 Sep; 16(5):349-360. PubMed ID: 28574202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of randomization and control in clinical trials.
    Urbach P
    Stat Med; 1993 Aug; 12(15-16):1421-31; discussion 1433-41. PubMed ID: 8248655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress toward a more ethical method for clinical trials.
    Kadane JB
    J Med Philos; 1986 Nov; 11(4):385-404. PubMed ID: 3819606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A critical review of the pragmatic clinical trial].
    Vallvé C
    Med Clin (Barc); 2003 Sep; 121(10):384-8. PubMed ID: 14565915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting potential safety issues in clinical trials by Bayesian screening.
    Gould AL
    Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian decision procedures based on logistic regression models for dose-finding studies.
    Whitehead J; Williamson D
    J Biopharm Stat; 1998 Jul; 8(3):445-67. PubMed ID: 9741859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust Bayesian sample size determination in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2008 Jun; 27(13):2290-306. PubMed ID: 18205170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications for trials in progress of publication of positive results.
    Fletcher A; Spiegelhalter D; Staessen J; Thijs L; Bulpitt C
    Lancet; 1993 Sep; 342(8872):653-7. PubMed ID: 8103149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.